The Efficacy of Immune Checkpoint Inhibitors as First-line Treatment in Microsatellite-instability- high Metastatic Colorectal Cancer
Main Author: | Jong Yoon Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Jin Publishing & Printing Co.
2021-05-01
|
Series: | The Korean Journal of Gastroenterology |
Online Access: | http://www.kjg.or.kr/journal/view.html?uid=5709&vmd=Full |
Similar Items
-
Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency
by: Romain Cohen, et al.
Published: (2021-03-01) -
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
by: Alessandra Raimondi, et al.
Published: (2021-04-01) -
Current Treatments of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitors—2020 Update
by: Gerhard Jung, et al.
Published: (2020-10-01) -
63 Microsatellite instability/mismatch repair biomarker testing disparities in patients with advanced colorectal cancer: Implications for immune checkpoint inhibitors
by: Bryan Iorgulescu
Published: (2020-11-01) -
Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer
by: Salomon M. Manz, et al.
Published: (2021-04-01)